04:17 PM EDT, 05/21/2024 (MT Newswires) -- Clay B Siegall, Director, President and CEO, on May 20, 2024, executed a purchase for 100,000 shares in Immunome ( IMNM ) for $1,388,072. Following the Form 4 filing with the SEC, Siegall has control over a total of 419,636 shares of the company, with 419,636 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1472012/000141588924013935/xslF345X03/form4-05212024_080525.xml

Price: 14.25, Change: +0.60, Percent Change: +4.40